Chimeric Therapeutics (ASX:CHM) - Webinar Presentation

27/10/2023 14:38:00

This video is not supported on your device. Click here for the original version.

Jennifer Chow - CEO - Chimeric Therapeutics (ASX:CHM) is a clinical-stage therapy company focused on bringing the promise of cell therapy to life for more patients with cancer.